Neuropace Inc
NPCE8.920USD
-0.070-0.78%
交易中 （美东）报价延迟15分钟
292.14M总市值
亏损市盈率 TTM
关于 Neuropace Inc 公司
NeuroPace, Inc. 是一家医疗设备公司。该公司致力于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。其新颖且差异化的 RNS 系统是一个大脑响应平台，可在癫痫发作源头提供个性化的实时治疗。该公司开发了 RNS 系统来解决耐药性癫痫的个性化性质，并为大脑任何部位的局灶性癫痫发作提供安全的治疗。RNS 系统是一种记录大脑活动数据的设备，允许临床医生不仅亲自监测患者，还可以远程监测患者。RNS 系统监测和分析大脑的电活动，识别患者特定的异常模式，并在癫痫发作源头提供治疗。该公司的 RNS 系统还用于治疗其他脑部疾病，包括抑郁症、冲动控制障碍、记忆障碍和创伤后应激障碍。
公司简介
公司代码NPCE
公司名称Neuropace Inc
上市日期Apr 22, 2021
CEOMr. Joel D. Becker
员工数量184
证券类型Ordinary Share
年结日Apr 22
公司地址455 N. Bernardo Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编94043
电话16502372700
网址https://www.neuropace.com/
公司代码NPCE
上市日期Apr 22, 2021
CEOMr. Joel D. Becker
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
589.53K
+0.39%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
74.39K
-1.77%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
37.35K
+2.98%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
15.59K
+10.17%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
12.04K
+10.46%
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
589.53K
+0.39%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
74.39K
-1.77%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
37.35K
+2.98%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
15.59K
+10.17%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
12.04K
+10.46%
收入明细
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2022
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
United States
22.52M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 6月4日 周三
更新时间: 6月4日 周三
持股股东
股东类型
持股股东
持股股东
占比
Accelmed Growth Partners Management Ltd
13.52%
OrbiMed Advisors, LLC
10.39%
Soleus Capital Management, L.P.
7.95%
Morgan Stanley & Co. LLC
7.70%
Polar Capital LLP
7.62%
Other
52.83%
持股股东
持股股东
占比
Accelmed Growth Partners Management Ltd
13.52%
OrbiMed Advisors, LLC
10.39%
Soleus Capital Management, L.P.
7.95%
Morgan Stanley & Co. LLC
7.70%
Polar Capital LLP
7.62%
Other
52.83%
股东类型
持股股东
占比
Private Equity
23.90%
Hedge Fund
20.38%
Investment Advisor/Hedge Fund
19.42%
Investment Advisor
13.63%
Research Firm
8.48%
Individual Investor
2.75%
Pension Fund
0.40%
Bank and Trust
0.04%
Insurance Company
0.02%
Other
10.96%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
183
29.20M
89.03%
-971.50K
2025Q1
183
29.76M
92.98%
+2.27M
2024Q4
144
26.53M
86.07%
-49.99K
2024Q3
134
26.01M
86.62%
-1.02M
2024Q2
129
25.88M
90.53%
+502.69K
2024Q1
131
24.82M
87.55%
-513.24K
2023Q4
113
24.06M
92.70%
-1.70M
2023Q3
103
24.86M
97.20%
-1.10M
2023Q2
106
24.30M
96.22%
-2.15M
2023Q1
107
24.47M
97.75%
-1.64M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Accelmed Growth Partners Management Ltd
4.43M
13.52%
--
--
Apr 09, 2025
OrbiMed Advisors, LLC
3.41M
10.39%
--
--
Mar 31, 2025
Soleus Capital Management, L.P.
2.61M
7.95%
+175.00K
+7.19%
Mar 31, 2025
Morgan Stanley & Co. LLC
2.52M
7.7%
+38.83K
+1.56%
Mar 31, 2025
Polar Capital LLP
2.50M
7.62%
-472.00K
-15.88%
Apr 09, 2025
First Light Asset Management, LLC
1.58M
4.83%
+1.58M
--
Mar 31, 2025
The Vanguard Group, Inc.
1.20M
3.65%
+140.78K
+13.32%
Mar 31, 2025
Armistice Capital LLC
1.15M
3.52%
+561.00K
+94.67%
Mar 31, 2025
Kent Lake PR LLC
950.00K
2.9%
-532.55K
-35.92%
Mar 31, 2025
DWS Investments UK Limited
923.92K
2.82%
+511.66K
+124.11%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Neuroscience and Healthcare ETF
0.63%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
Principal U.S. Small-Cap ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
占比0.63%
iShares Micro-Cap ETF
占比0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.03%
iShares Russell 2000 Growth ETF
占比0.02%
Principal U.S. Small-Cap ETF
占比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
